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had primary level of education, 551 (358:HP, 193:HI) were employed. Six hundred 
and fifty six (431:DP, 225:HI) having family history of diabetes. The mean diabetes 
knowledge score was 8.2±2.1, (8.5±2.7:DP, and 8.1±2.6:HI). There is no significance 
different was found between the diabetes knowledge score of both the groups (i.e. 
diabetes patients and healthy individuals), p < 0.05. ConClusions: Results of 
the present study show that there is no significance difference between the two 
groups i.e. diabetes patients and healthy individuals regarding the knowledge 
regarding diabetes. It is important to educate both patients and healthy individu-
als for management and prevention of the disease.
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objeCtives: The present study was conducted to evaluate the knowledge regarding 
diabetic in healthy population of Quetta city, Pakistan. Methods: A questionnaire 
based, cross-sectional observational study was carried out. All residence of the area 
were targeted from July to October 2013. The questionnaire comprised of two parts. 
The first part was consist of demographic characteristics. The second part were 
consist of 15 question related to diabetes basic knowledge. Descriptive statistics 
were applied to summarize the data. Results: A total of 1000 general people were 
approached and 840 respondents were agreed and participated in the study. Majority 
of the respondents (72.0%) belonged to age group 18-40 years with almost equal in 
gender distribution. Majority (51.3%) had family history of diabetes. Majority (96.7%) 
had knowledge about disease and its nature (64.0%), and knew about symptoms 
(62.5%). Fifty four percent said obesity and (46.7%) said alcohol or smoking are major 
causes for diabetes. Seventy eight percent considered diabetes is as heredity.. Fifty 
percent of participants considered mental stress and high blood pressure being 
risk factors for diabetes. Fifty Eight percent considered it as treatable disease, while 
45.6% said it require lifelong treatment. Sixty eight percent said regular walk or 
exercise are important for diabetes control, 83.3% believed that diet control is impor-
tant in diabetes prevention, majority (76.7%) considered the uncontrolled diabetes 
can cause complications and (43.3%) believed that uncontrolled diabetes can cause 
death. Although majority (56.9%) of the respondents considered glucose monitoring 
is necessary, yet only few said regular walk or exercise are important for diabetes 
control. Only 17.1%) considered the uncontrolled diabetes can cause complications 
and 31.4% believed that uncontrolled diabetes can cause death. ConClusions: 
The study concluded that although the general populations have knowledge about 
the diabetes but they lack vital information regarding its treatment, management 
and severity of the disease.
DiABetes/enDOCRine DisORDeRs – Health Care use & Policy studies
PDB41
tHe exPAnDing ROle Of tHe PAtient VOiCe in meDiCAl DeCisiOn mAKing 
in AsiA
Victor TW1, Stankus AP1, Li S2
1Kantar Health, Princeton, NJ, USA, 2Kantar Health, Shanghai, China
objeCtives: Self-reported indices of health care related attitudes and behaviors, 
health status, and work productivity are compared between Chinese and Japanese 
diabetics to illustrate the various kinds of information that can only come from 
the patient that is pertinent to the medical decision making process. Methods: 
Data were obtained from the 2012 Japan (N= 30,000) National Health and Wellness 
Survey (NHWS) and 2013 China (N= 19,987) NHWS, administered on-line to rep-
resentative adult samples (18+ years). Generalized linear models and Tukey’s 
HSD procedure were used to estimate differences between respondents without 
diabetes (Japan n= 25,338; China n = 16,816), respondents with Type 2 diabetes 
without complications (Japan n= 929; China n= 408), and respondents with Type 2 
diabetes with complications (Japan n = 125; China n = 184). Respondent age, sex, 
and BMI served as covariates in all models. The SF-36 and the WPAI were used to 
measure health status and utilities and work productivity respectively. Results: 
The relationship between the patient reported outcomes of mental and physi-
cal health status, level of depression, health utilities, work productivity, activity 
impairment, days missed from work and level of diabetic condition was consistent. 
Diabetic complications were associated with greater levels of health/activity/work 
impairment and lower health utilities (p < .0001 for all comparisons). Chinese 
respondents reported greater levels of impairment and lower health utilities rela-
tive to Japanese respondents (p < .0001 for all comparisons). ConClusions: The 
patient voice varies across countries, cultures, and conditions. Treating the whole 
patient versus treating only the presenting disease requires a shift in how health 
care is delivered and medical decisions are made. Patients can provide reliable 
and valid information regarding their health and wellness status through the use 
of validated methods and tools. Amplifying the patient voice and integrating it 
with clinical expertise may be the best way maximize the positive outcomes for 
the patient.
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objeCtives: Medication costs accounted for 25% of total medical expenses in 
Taiwan. Reduction in price of drug is the major policy to control the medication 
costs. Diabetes drugs is a major factor contributing to high and rapidly growing pre-
scription medication costs. This study was to examine the determinants for diabetes 
drug expenditures inflation in Taiwan’s National Health Insurance (NHI). Methods: 
This retrospective and longitudinal used NHI claim data to quantify the different 
(95%CI: -0.11, 0.11). T2DM patients with complications had systematically higher 
TTO values than those without complications, with the difference being -0.10 
(95%CI: -0.23, 0.03). ConClusions: It appears that diabetes and its complications 
affect patients’ valuation of health states. As a result, the EQ-5D-3L health-state 
values based on the general population may underestimate the utility of health 
interventions for T2DM.
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objeCtives: The study aimed to investigate the utilization and expenditures 
of medical resources, including outpatient visits, hospitalizations, and produc-
tivity loss for insulin-treated diabetes patients. Methods: A survey based on 
self-designed questionnaire was conducted in 7 third-grade class-A hospitals 
among eastern, central and western regions of China from July to September of 
2012, with inclusion criteria of type 1 and type 2 diabetes patients treated with 
insulin. Diabetes duration and glycemic control for included patients, frequency 
and expenditures of outpatient visit and hospitalization, and time spending of 
outpatient visit were collected. Descriptive analysis of the data was performed by 
SPSS 19.0. Results: 602 eligible respondents (95.0% type 2 diabetes, 48.2% male) 
were included, with mean age of 62.15±13.06 years, mean diabetes duration of 
10.62±8.23 years, mean fasting plasma glucose of 8.05±2.89 mmol/L; mean haemo-
globin A1c of 7.24±2.10%. Average frequency of outpatient visit was 14.37 times per 
year, and average cost per outpatient visit was 696.70 CNY. 36.3% of patients were 
hospitalized because of diabetes and its complications in the previous year, with 
the frequency of 1.36 times per year and average cost of 11461.51 CNY, resulted in 
annual hospitalization cost of 15587.65 CNY per inpatient. Total annual medical 
expenditure was estimated to be 11985.33 CNY per patient, including 10011.58 
CNY for outpatient visits and 1973.75 CNY for hospitalizations. In addition, an 
average of 5.05 hours, including the traffic time, was spent for outpatient visit, 
and 3.37 more hours were needed for rural patients as compared to urban patients 
(8.11 hours vs 4.74 hours). ConClusions: In China, Diabetes consumed a great 
deal of medical resources and imposed a heavy burden on patients treated with 
insulin, especially when hospitalization needed. More attentions should be paid 
on diabetes prevention and management to reduce medical resource utilization 
and burden of diabetes.
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objeCtives: The present study aimed to assess disease knowledge of the diabetic 
patients in Quetta city, Pakistan. Methods: A questionnaire based, cross-sectional 
observational study was carried out. All residence of the area (age 18 and above) 
were targeted. The study was conducted from July to October 2013. The question-
naire comprised of two parts. The first part was consist of demographic characteris-
tics. The second part were consist of 15 question related to diabetes basic knowledge. 
Descriptive statistics were applied to summarize the data. Results: A total of 457 
registered diabetes patients were approached, and 408 patients were agreed and 
participated in the study. Majority of the patients (n= 285, 69.9%) belonged to age 
group 41-60 years with almost equal in gender distribution. One hundred and sixty 
nine (41.4%) had primary level education and majority (n= 225, 55.1%) had family his-
tory of diabetes. Majority of the respondents had knowledge about disease (98.5%) 
and its nature (68.4%). Only 280 patients knew about symptoms. 217 (49.3%) patients 
said obesity can cause diabetes, 49.3% said consumption of sweets and high calories 
food, 44.8% said alcohol or smoking are major reasons of having diabetes. Seventy 
percent of the respondents considered it as heredity in nature. Three hundred and 
twenty five (67.8%) considered mental stress and high blood pressure being risk 
factor. Majority (69.1%) considered it as treatable disease, while 64% said it require 
lifelong treatment. Although majority (n= 344, 71.7%) of the respondents considered 
glucose monitoring is necessary, yet only few said regular walk or exercise are 
important for diabetes control. Only 38.4% considered the uncontrolled diabetes 
can cause complications and 34.2% believed that uncontrolled diabetes can cause 
death. ConClusions: The study concluded that although the general populations 
have knowledge about the diabetes but they lack vital information regarding its 
treatment, management and severity of the disease.
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objeCtives: The present study was design to compare the knowledge regarding 
diabetes between the diabetic patients and healthy population in Quetta city, 
Pakistan. Methods: A questionnaire based, cross-sectional observational study 
was carried out. All the registered diabetes patients (DP) of Bolan Medical Complex 
hospital and Sandman Provisional hospital were targeted and for healthy individ-
ual (HP), all residence of the area (age 18 and above) were targeted. The study was 
conducted from July to October 2013. The questionnaire comprised of two parts. 
The first part was consist of demographic characteristics. The second part were 
consist of 15 question related to diabetes basic knowledge. Descriptive statistics 
were applied to summarize the data. Mann-Whitney test was used to compare the 
study groups. Results: Out of 1248 participants 623 (408:DP, 215:HI) were males 
with mean age of 36.9±9.9 (38.6±9.5:HP, 32.7±9.4) years, majority 462 (352:DP, 110:HI) 
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it is important to explore the behavior change techniques (BCTs) employed and 
their contribution to pooled effectiveness. This paper aimed to estimate the pooled 
effectiveness of OAD adherence-enhancing interventions and identify BCTs applied 
that had a modifying effect on the pooled estimate of effectiveness. Methods: We 
performed a systematic review and meta-analysis of RCTs conducted to evaluate 
the effectiveness of adherence-enhancing interventions targeting adults receiv-
ing OADs. Articles were searched using PubMed, Embase, Psych-Info, the Cochrane 
Library, CINAHL PLUS, Current Contents Connect and Web of science, and included 
articles references and relevant review articles. Two authors independently selected 
eligible articles and coded study details including BCTs applied in intervention 
and control groups. Each intervention’s effectiveness (effect size) was estimated 
using Hedges’s g. Pooled effectiveness and its heterogeneity (Higgins I2) were esti-
mated using a random effect model. For BCTs applied in intervention but not in 
control groups, we assessed their modifying effect on the pooled effectiveness by 
comparing interventions in which a specific BCT was applied with those in which 
it was not. Results: A total of 10 studies were included. Globally, the pooled effec-
tiveness (g) was 0.21 (95%CI= -0.05–0.47; I2= 82%). Out of eight BCTs analysed, cope 
with side-effects (P= 0.003) and general intention formation (P= 0.006) had a modifying 
effect on the pooled effectiveness. The pooled effectiveness of interventions, in 
which cope with side-effects was applied, was moderate (g= 0.64; 95%CI= 0.31–0.96; 
I2= 56%). ConClusions: Globally, effectiveness of interventions offered in inter-
vention groups was almost equivalent to that of those offered in control groups. 
However, interventions that include helping people to cope with side-effects, when 
this was not done for control patients, are particularly effective in improving adher-
ence to OAD.
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objeCtives: Pharmaceutical expenditure is determined by both price and volume. 
Volume control is important despite that public policies to control drug expenditure 
in Korea have focused on price control. In this study, we decomposed growth of 
diabetes drug expenditure in Korea. Methods: The study used National Health 
Insurance Service (NHIS) claims data on diabetes drugs for 10 years between January 
1, 2003 and December 31, 2012. We included new or incrementally modified diabetes 
drugs for which listing prices were negotiated between firms and NHIS and their 
generic counterparts. Drug expenditure was decomposed into price and volume. 
Volume is further decomposed into the proportion of monthly volume for each drug 
in its therapeutic class (composition mix), the proportion of sum of quantity used 
in new and existing drugs (therapeutic mix) for a given therapeutic group, and the 
total volume used for new and existing drugs (total volume). We generated Fisher’s 
Ideal Index to calculate contribution of each component of total drug expenditure 
to its growth. Results: The price of diabetes drugs as a whole decreased total drug 
expenditure since 2006, whereas growth of volume explained most of the growth 
of total pharmaceutical expenditure during 2006 and 2010. Particularly between 
2011 and 2012 when price decreased 12% due to nationally implemented price 
cut for almost all listed drugs, the volume still increased 5%. Further decomposi-
tion of volume showed that the change in the proportion of volume of new diabe-
tes drugs in total volume minimally contributed to growth in total diabetes drug 
expenditure. ConClusions: Our results showed that growth in quantity (volume) 
index explained most of the growth in total pharmaceutical expenditure for diabe-
tes drugs, whereas price index overall decreased for the same time period. These 
results imply that volume control is more critical for policy measured related to 
drug expenditure control.
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objeCtives: Lipohypertrophy (LH) is a relatively common complication of injecting 
insulin. It is reported to impair insulin absorption, and may increase total daily dose 
(TDD) of insulin and associated costs. The economic burden of LH is unknown in 
China. This study aims to evaluate the effects of LH on TDD of insulin and explore 
potential health economic implications for China. Methods: The following data 
were extracted from literature review and the IMS Health Report (Diabetes China 
2013): (i) insulin-injecting diabetes population in China1, (ii) prevalence of LH among 
insulin-injecting Chinese patients2, (iii) TDD of insulin among patients with LH 
(estimated from a recent Spanish study3), (iv) average unit cost of insulin in China1. 
Cost of excess insulin use was calculated per annum. All monetary values were 
converted to 2013 RMB, with a RMB-USD exchange rate of 6.14:1. Results: There 
are approximately 8.4 million insulin injectors in China, mostly type 2 diabetes 
(T2D)1. The prevalence of LH in China was previously reported to be 31%2. In the 
Spanish study, patients with T2D and LH used 21 IU/day more insulin3; we estimated 
15 IU/day excess usage vs non-LH injectors in China. The average insulin price in 
China is 0.215 RMB per IU1. The estimated cost of excess insulin use due to LH is 
approximately 3,065,233,500 RMB ($498,991,500 USD) per year. ConClusions: LH 
may represent a significant, addressable, economic burden in China due to excess 
insulin consumption. Taking steps to reduce LH may reduce health care costs in 
China. Additional studies should be conducted on LH prevalence, glycemic control 
(HbA1c, hyper- and hypoglycemia) and health resource utilization patterns spe-
cifically among the Chinese insulin-injecting population to validate and extend 
these findings.
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factors driving to increases in diabetes medication costs from 2000 to 2010. Changes 
in diabetes drug spending are decomposed to eight components: (1) the growth of 
user population; (2) the growth of number of prescription per user; (3) the growth 
of number of drug item of per prescription of established drugs; (4) the growth of 
number of drug item of per prescription of new entrant drugs; (5) the growth of 
Defined Daily Dose (DDD) of established drugs of average drug item per prescrip-
tion; (6) the growth of DDD of new entrant drugs of average drug item per prescrip-
tion; (7) change of average price of established drugs per prescription ; (8) change 
of average price of new entrant drugs per prescription; (9) change in therapeutic 
and strength mix. Results: Changes in user population, number of drug item of 
per prescription, and therapeutic and strength mix caused diabetes spending to 
increase. The drug price and DDD caused diabetes spending to decrease. Over half 
of drug spending growth was accounted for user population. The rest of spending 
growth was from the change in drug treatment intensity. The results also reveal 
the care pattern change to more drug item with low-dose therapy. ConClusions: 
The results suggest that use drug pricing policy to lower drug spending is limited. 
The policy makers should consider put more effort to manage treatment intensity 
in diabetes medication.
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objeCtives: Physicians’ generic pharmaceutical adoption are responsible for 
patients, insurance payers, and their own interests. This study examines this dou-
ble agency problem for physicians by using Taiwanese data, because physicians 
can both prescribe and dispense drugs in Taiwan. The universal health care system 
in Taiwan also causes the problem to be a public concern. Methods: This study 
begins with a theoretical model of physicians’ prescription behavior that includes 
both the patients’ and physicians’ utilities, and government’s share of patients’ 
medical expenditure. To empirically estimate this model by using the Taiwanese 
data, a panel framework is structured by adopting visit-physician-drug as a unit 
of observation. Empirical results were obtained after controlling the physicians’, 
patients’, and hospitals’ characteristics; and time-, location-, and drug-fixed effects. 
The physicians’ unobserved, time-invariant heterogeneity was also controlled by 
applying Chamberlain’s correlated random effects probit model. Results: The 
empirical results show that a larger price difference between brand-name and 
generic drugs increases physicians’ likelihood for prescribing generic prescriptions. 
However, for physicians in hospitals, this effect decreases as the payer’s cost share 
percentage increases. These results indicate that physicians’ prescriptions decision 
internalize patients’ utility but not the payer’s cost. This study also demonstrates 
that physicians who are more responsive to profits prescribed more generic drugs, 
including owners of hospitals and clinics, and physicians in clinics and private 
institutions. However, this effect decreases as the number of competitors in the drug 
market increases. ConClusions: The reported findings suggest that physicians’ 
double agent role in a universal health care system is responsible for part of the 
pharmaceutical expenditure in Taiwan, where brand-name drugs were probably 
prescribed more than necessary. Taiwanese government is advised to encourage 
generic prescriptions by providing incentives for physicians, increasing the patients’ 
share of their medication cost, and increasing patients’ and physicians’ access to 
the information on generic drugs.
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objeCtives: Among individuals newly treated with oral antidiabetes drugs (AD), 
to assess the effect of pharmacy loyalty on compliance with AD and on the use of 
guidelines-recommended medications: 1) ACE inhibitor (ACEi) or angiotensin recep-
tor blocker (ARB); 2) lipid-lowering drug. Methods: Using Quebec administrative 
databases we carried out a cohort study of individuals aged ≥ 18 years who had 
started an OAD between 2000 and 2006 and for whom we had at least 3 years of 
follow-up after OAD initiation. Individuals who had filled all their prescriptions in 
the same pharmacy during the 2nd year after OAD initiation were considered loyal. 
Compliance with OAD (Medication Possession Ratio ≥ 80%) and use of an ACEi/ARB 
and of a lipid-lowering drug were measured in the 3rd year. Outcomes were assessed 
using multivariate logistic regressions. Results: Among 97,927 eligible individuals, 
64% were loyal to their pharmacy, 64% were compliant with their AD, 64% used an 
ACEI/ARB and 60% used a lipid-lowering drug. Loyal individuals were more likely to 
be compliant with their AD (Odds ratio: 1.26; 95% CI: 1.22-1.30), to use an ACEI/ARB 
(1.17; 1.14-1.21) and to use a lipid-lowering drug (1.15; 1.12-1.18). ConClusions: 
Pharmacy loyalty is associated with a better quality of AD use. It is likely due to 
the fact that pharmacists can better play their role in optimizing their clients’ drug 
use for patients loyal to their pharmacy as they can then rely on recorded drug use 
information that is comprehensive.
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objeCtives: OAD adherence interventions are available but their pooled effective-
ness has not yet been estimated. Also, in order to develop effective interventions, 
